Education
About Us
Working with TipRanks
Follow Us
Guardant Health (GH)
NASDAQ:GH
GH Analyst Ratings
Strong Buy
21 Buy
0 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
GH Stock 12 Month Forecast
Average Price Target
$69.32
▲(10.31% Upside)
| Highest Price Target$80.00 | Average Price Target$69.32 | Lowest Price Target$60.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
Barclays
$60→$70
Buy
11.39%
Upside
Reiterated
10/02/25
Jefferies
$60→$75
Buy
19.35%
Upside
Reiterated
09/26/25
Canaccord Genuity
$65→$75
Buy
19.35%
Upside
Reiterated
09/26/25
Leerink Partners
$70→$75
Buy
19.35%
Upside
Reiterated
09/26/25
Wolfe Research
$75
Buy
19.35%
Upside
Upgraded
09/25/25
TD Cowen
$63→$72
Buy
14.58%
Upside
Reiterated
09/25/25
Guardant Health's Strong Growth Trajectory and Unique Oncology Approach Earns Buy RatingWe believe Guardant generally delivered on updates in these areas and gave a more thorough view on the technology path there. So why was the stock down (3%)? The stock was up 92% into today, investors expected an optimistic day, and while '28 guidance was raised (and is now $200M further ahead of consensus), Shield revenue guidance - which has been arguably the biggest focus - remained in place with higher price though lower volumes.
UBS
$70→$80
Buy
27.31%
Upside
Reiterated
09/25/25
William Blair
―
Buy
―
Reiterated
09/25/25
Bernstein
$60
Buy
-4.52%
Downside
Reiterated
09/25/25
J.P. Morgan
$60→$70
Buy
11.39%
Upside
Reiterated
09/25/25
Mizuho Securities
$65→$70
Buy
11.39%
Upside
Reiterated
09/25/25
BTIG
$70→$80
Buy
27.31%
Upside
Reiterated
09/25/25
Guggenheim
$56→$67
Buy
6.62%
Upside
Reiterated
09/24/25
Wells Fargo
$72
Buy
14.58%
Upside
Initiated
09/22/25
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Barclays
$60→$70
Buy
11.39%
Upside
Reiterated
10/02/25
Jefferies
$60→$75
Buy
19.35%
Upside
Reiterated
09/26/25
Canaccord Genuity
$65→$75
Buy
19.35%
Upside
Reiterated
09/26/25
Leerink Partners
$70→$75
Buy
19.35%
Upside
Reiterated
09/26/25
Wolfe Research
$75
Buy
19.35%
Upside
Upgraded
09/25/25
TD Cowen
$63→$72
Buy
14.58%
Upside
Reiterated
09/25/25
Guardant Health's Strong Growth Trajectory and Unique Oncology Approach Earns Buy RatingWe believe Guardant generally delivered on updates in these areas and gave a more thorough view on the technology path there. So why was the stock down (3%)? The stock was up 92% into today, investors expected an optimistic day, and while '28 guidance was raised (and is now $200M further ahead of consensus), Shield revenue guidance - which has been arguably the biggest focus - remained in place with higher price though lower volumes.
UBS
$70→$80
Buy
27.31%
Upside
Reiterated
09/25/25
William Blair
―
Buy
―
Reiterated
09/25/25
Bernstein
$60
Buy
-4.52%
Downside
Reiterated
09/25/25
J.P. Morgan
$60→$70
Buy
11.39%
Upside
Reiterated
09/25/25
Mizuho Securities
$65→$70
Buy
11.39%
Upside
Reiterated
09/25/25
BTIG
$70→$80
Buy
27.31%
Upside
Reiterated
09/25/25
Guggenheim
$56→$67
Buy
6.62%
Upside
Reiterated
09/24/25
Wells Fargo
$72
Buy
14.58%
Upside
Initiated
09/22/25
Best Analysts Covering Guardant Health
1 Month
xxx
Success Rate
8/12 ratings generated profit
Average Return
+6.47%
reiterated a xxx
rating 8 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 66.67% of your transactions generating a profit, with an average return of +6.47% per trade.
3 Months
xxx
Success Rate
9/16 ratings generated profit
Average Return
+11.28%
reiterated a xxx
rating 2 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 56.25% of your transactions generating a profit, with an average return of +11.28% per trade.
1 Year
Success Rate
12/13 ratings generated profit
Average Return
+44.62%
reiterated a buy rating 13 days ago
Copying Daniel Brennan's trades and holding each position for 1 Year would result in 92.31% of your transactions generating a profit, with an average return of +44.62% per trade.
2 Years
xxx
Success Rate
13/13 ratings generated profit
Average Return
+76.25%
reiterated a xxx
rating 13 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +76.25% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
GH Analyst Recommendation Trends
Rating
Jun 25
Jul 25
Aug 25
Sep 25
Oct 25
Strong Buy
1
2
3
2
1
Buy
30
32
20
34
27
Hold
8
5
6
3
3
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
39
39
29
39
31
Each month's total comprises the sum of three months' worth of ratings.
GH Financial Forecast
GH Stock Forecast FAQ
What is GH’s average 12-month price target, according to analysts?
Based on analyst ratings, Guardant Health’s 12-month average price target is 69.32.
What is GH’s upside potential, based on the analysts’ average price target?
Guardant Health has 10.31% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is GH a Buy, Sell or Hold?
Guardant Health has a consensus rating of Strong Buy which is based on 21 buy ratings, 0 hold ratings and 0 sell ratings.
What is Guardant Health’s price target?
The average price target for Guardant Health is 69.32. This is based on 21 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $80.00 ,the lowest forecast is $60.00. The average price target represents 10.31% Increase from the current price of $62.84.
The highest analyst price target is $80.00 ,the lowest forecast is $60.00. The average price target represents 10.31% Increase from the current price of $62.84.
What do analysts say about Guardant Health?
Guardant Health’s analyst rating consensus is a Strong Buy. This is based on the ratings of 21 Wall Streets Analysts.
How can I buy shares of GH?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.